Holen Sie sich die Stockscreener-App
1,213.91
1.86%
22.17
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LLY?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lilly Eli Co Aktie (LLY) Neueste Nachrichten
Charles River Laboratories International (CRL) On Lilly TuneLab Deal And The Valuation Debate - simplywall.st
Eli Lilly (LLY) Faces China Trial Probe While Handing Verzenios Rights To Innovent - simplywall.st
Is Eli Lilly (LLY) One of Billionaire Cliff Asness’ Best Healthcare Stock Picks ? - Insider Monkey
Why Is Eli Lilly (NYSE:LLY) Obesity Pill In Focus? - Kalkine Media
Medicare Expands Access to GLP-1 Drugs, Boosting Eli Lilly (LLY) and Novo Nordisk (NVO) - GuruFocus
Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China - Benzinga
$100 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today - Benzinga
Eli Lilly & Co. highlights its role in innovative diabetes care - AD HOC NEWS
Mounjaro from Eli Lilly & Co.dual-action diabetes drug expands US reach - AD HOC NEWS
Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results - FXEmpire
Eli Lilly (LLY) and Novo Nordisk (NVO) to Benefit from New Medic - GuruFocus
Medicare opens access to GLP-1 weight-loss drugs (LLY:NYSE) - Seeking Alpha
$Eli Lilly and Co (LLY.US)$ break and retest. 1300+ might be understatement from me. - Moomoo
Hybio challenges Eli Lilly with FDA bid for tirzepatide generic - China Daily
Hanmi Receives $75 Million Upfront from Eli Lilly - Businesskorea
Korea Lilly names Komatsu Seiya CEO to accelerate innovation pushCHOSUNBIZ - Chosunbiz
Innovent and Lilly Expand China Oncology Partnership with Verzenios Commercialisation Agreement - BioPharma APAC
Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals - AOL.com
Pennsylvania invests millions to train workers for Eli Lilly facility opening in 2031 - PennLive.com
Lilly taps Abbisko for $1.9B discovery deal - BioWorld News
Why is Eli Lilly stock sliding today? - Investing.com
U.S. Stocks Move | Eli Lilly and Co (LLY.US) Drops Over 2% as Weight-Loss Drug Included in Medicare Reimbursement for the First Time - 富途牛牛
Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters? - Yahoo Finance
Eli Lilly, Regeneron Join FDA Pilot Designed To Accelerate US Manufacturing Readiness - Benzinga
Eli Lilly Transfers Commercialization Rights for Breast Cancer Drug in ChinaU.S. News - U.S. News - Money
Eli Lilly transfers commercialization rights for breast cancer drug in China - Reuters
Eli Lilly Upgraded, Carvana Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Eli Lilly (LLY) Stock Hits $1,230 in June 2026 — Strong Sales of Mounjaro & Zepbound Drive Gains - FXLeaders
Eli Lilly And Company (NYSE:LLY) Advances Metabolic Medicine Frontier - Kalkine Media
The loophole in Trump’s obesity drug deal with Eli Lilly and Novo Nordisk - STAT
Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow - The Motley Fool
5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX - The Motley Fool
Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years - The Motley Fool
Lilly hands Innovent China rights to breast cancer drug Verzenios - Stock Titan
LLYLilly(Eli) & Co Latest SEC Filings - Finviz
Eli Lilly (LLY) Joins FDA PreCheck Pilot Program to Enhance Drug Manufacturing - GuruFocus
Eli Lilly (LLY) Joins FDA Pilot Program to Strengthen U.S. Drug Manufacturing - GuruFocus
Lilly, Regeneron selected for US program to review new manufacturing plants faster - Reuters
Eli Lilly (LLY) Joins FDA PreCheck Pilot Program for Manufacturi - GuruFocus
Lilly, Regeneron selected for US program to review new manufacturing facilities faster, CNBC reports - Yahoo
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities - CNBC
How Is Eli Lilly (NYSE:LLY) Positioned As Healthcare Hits Record Highs? - Kalkine Media
Lilly partners with P2U on private Mounjaro dispensing service - Pharmacy Magazine
The Investment Case for Eli Lilly and Co (LLY): How Financial Gr - GuruFocus
U.S. Stock Market Update | Eli Lilly and Co (LLY.US) hits a new all-time high, up over 14% year-to-date - 富途牛牛
Here's Why Shares of Eli Lilly Hit an All-Time High on Friday - The Globe and Mail
Jefferies Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,350 - 富途牛牛
Lilly (LLY) Moves 7.1% Higher: Will This Strength Last? - Yahoo Finance
Lilly launches home delivery service for privately prescribed medicines - The Pharmacist News
ZAWYA: Lilly and Department of Health – Abu Dhabi aim to advance management of obesity and alzheimer’s disease - TradingView
Eli Lilly and Company (LLY) Up More Than 6% Over the Past Month, Can it Move Higher? - Insider Monkey
Inside Lilly's biotech startup factory - The Korea Herald
Is Eli Lilly and Company (LLY) Among the Best AI-Powered Healthcare Stocks to Buy According to Hedge Funds? - Insider Monkey
Nesbitt to roll out weight loss drugs with support from Mounjaro maker Eli Lilly - Belfast News Letter
Lilly launches “The Memory Radio Station” across Europe, inviting the public to visually reconstruct fading memories through GenAI - Eli Lilly and Company
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management - investor.lilly.com
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Encyclopedia Britannica
List of 38 Acquisitions by Lilly (Jun 2026) - Tracxn
Eli Lilly (LLY) and BioArctic AB Enter into Research and Collaboration Agreement - Insider Monkey
Here’s What the Street Thinks About Eli Lilly and Company (LLY) - Insider Monkey
Eli Lilly Stock (LLY) Opinions on Analyst Notes Amid Obesity Drug Shifts - Quiver Quantitative
Eli Lilly & Co Soars on Drug Pipeline Breakthroughs - TipRanks
3.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):